Purchases and Sales Made in Q3 2018 in Intellipharmaceutics International Inc. (IPCIF)
This table provides information about the institutional ownership of Intellipharmaceutics International Inc. (IPCIF) during Q3 2018. The information is specifically focused on institutions that hold shares of Intellipharmaceutics International Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2018
Q3 2018
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
860KNew |
$2.06M - $4.56M
|
860K
$129K
|
|
|
Nov 14, 2018
Q3 2018
|
Barclays PLC
London, X0 |
BUY
|
- |
1.78KNew |
$4.26K - $9.41K
|
1.78K
$266
|
|
|
Oct 29, 2018
Q3 2018
|
Financial Architects, Inc
Marlton, NJ |
BUY
|
- |
200New |
$480 - $1.06K
|
200
$30
|
|
|
Nov 13, 2018
Q3 2018
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
100New |
$240 - $530
|
100
$15
|
|
|
Aug 30, 2024
Q3 2018
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
BUY
|
- |
7New |
$16.8 - $37.1
|
7
$1.05
|
|
|
Nov 14, 2018
Q3 2018
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
1New |
$2.4 - $5.3
|
1
$0.15
|
|
|
Nov 13, 2018
Q3 2018
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|